| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
110,748 |
89,165 |
$25.07M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42,640 |
37,380 |
$991K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41,314 |
36,617 |
$904K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26,337 |
24,687 |
$132K |
| 99215 |
Prolong outpt/office vis |
3,360 |
3,184 |
$114K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
3,885 |
3,847 |
$90K |
| 81002 |
|
2,413 |
2,296 |
$63K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,266 |
2,247 |
$58K |
| 80305 |
|
1,847 |
1,725 |
$37K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,553 |
1,529 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,379 |
4,221 |
$26K |
| 96127 |
|
6,775 |
6,423 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,189 |
3,881 |
$20K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,933 |
1,915 |
$19K |
| 81025 |
|
784 |
763 |
$16K |
| 91300 |
|
96 |
94 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,712 |
1,601 |
$13K |
| 87428 |
|
20,216 |
18,877 |
$9K |
| 91301 |
|
95 |
94 |
$9K |
| 20553 |
|
1,231 |
1,142 |
$8K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,283 |
1,231 |
$6K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
503 |
448 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
549 |
536 |
$6K |
| 20610 |
|
303 |
262 |
$5K |
| 90686 |
|
224 |
222 |
$5K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
203 |
135 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
559 |
548 |
$3K |
| 2014F |
|
863 |
834 |
$3K |
| 99490 |
Ccm add 20min |
115 |
109 |
$3K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
17 |
12 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
521 |
493 |
$2K |
| 86580 |
|
28 |
26 |
$2K |
| 90633 |
|
86 |
85 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,166 |
1,947 |
$2K |
| 90656 |
|
58 |
58 |
$2K |
| 95886 |
|
12 |
12 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,912 |
2,763 |
$2K |
| 90756 |
|
56 |
56 |
$1K |
| 90677 |
|
92 |
92 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
215 |
208 |
$1K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
833 |
738 |
$1K |
| 90734 |
|
74 |
74 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
103 |
102 |
$1K |
| 90651 |
|
90 |
89 |
$883.36 |
| 90696 |
|
33 |
31 |
$790.23 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
37 |
36 |
$786.12 |
| 96160 |
|
69 |
67 |
$735.28 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
98 |
90 |
$600.83 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
41 |
41 |
$595.93 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,686 |
1,671 |
$588.14 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
93 |
87 |
$550.95 |
| 99205 |
Prolong outpt/office vis |
84 |
83 |
$535.98 |
| 99406 |
|
771 |
732 |
$526.27 |
| 3288F |
|
53 |
52 |
$495.16 |
| 95251 |
|
284 |
268 |
$408.10 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
12 |
12 |
$384.01 |
| 99385 |
|
19 |
19 |
$367.23 |
| 87807 |
|
276 |
271 |
$340.46 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
131 |
129 |
$307.80 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
358 |
314 |
$289.47 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
471 |
440 |
$279.12 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
83 |
83 |
$256.66 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
15 |
15 |
$208.89 |
| 0011A |
|
121 |
121 |
$207.95 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
409 |
409 |
$203.14 |
| 0012A |
|
111 |
111 |
$195.88 |
| 90715 |
|
53 |
53 |
$164.13 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$106.25 |
| 90694 |
|
17 |
17 |
$104.82 |
| 90661 |
|
13 |
13 |
$91.67 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
46 |
27 |
$82.82 |
| 90710 |
|
15 |
15 |
$78.89 |
| 4450F |
|
20 |
19 |
$29.20 |
| 90832 |
Psychotherapy, 30 minutes with patient |
19 |
19 |
$14.90 |
| 20552 |
|
13 |
13 |
$11.75 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
27 |
27 |
$8.45 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
25 |
$7.42 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
89 |
84 |
$2.57 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$0.15 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
325 |
321 |
$0.00 |
| 90461 |
|
1,109 |
1,102 |
$0.00 |
| 99442 |
|
14 |
14 |
$0.00 |
| 3725F |
|
58 |
58 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
526 |
524 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
172 |
164 |
$0.00 |
| 0002A |
|
290 |
290 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
212 |
212 |
$0.00 |
| 90671 |
|
94 |
94 |
$0.00 |
| 0003A |
|
56 |
56 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
90 |
86 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
19 |
19 |
$0.00 |
| 86756 |
|
97 |
95 |
$0.00 |
| 0013A |
|
33 |
33 |
$0.00 |
| G9509 |
Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 |
98 |
94 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
17 |
17 |
$0.00 |
| 0071A |
|
13 |
13 |
$0.00 |
| 90670 |
|
13 |
13 |
$0.00 |
| 0001A |
|
202 |
201 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
79 |
79 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
896 |
866 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
13 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
13 |
12 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
18 |
17 |
$0.00 |
| 1101F |
|
45 |
43 |
$0.00 |